From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 33,318,001 shares, representing 1.9% for $3,591.07 million under the buyback announced on December 10, 2021.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
104.5 USD | -0.35% | -2.00% | -5.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.12% | 182B | |
-4.31% | 103B | |
-5.61% | 66.94B | |
+10.33% | 46.73B | |
-7.78% | 45.14B | |
+5.82% | 41.57B | |
+16.99% | 30.48B | |
+14.00% | 24.26B | |
-5.83% | 23.58B | |
-11.41% | 22.24B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Tranche Update on Abbott Laboratories's Equity Buyback Plan announced on December 10, 2021.